Chronic inflammatory arthritis drives systemic changes in circadian energy metabolism.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
03 05 2022
Historique:
entrez: 28 4 2022
pubmed: 29 4 2022
medline: 3 5 2022
Statut: ppublish

Résumé

Chronic inflammation underpins many human diseases. Morbidity and mortality associated with chronic inflammation are often mediated through metabolic dysfunction. Inflammatory and metabolic processes vary through circadian time, suggesting an important temporal crosstalk between these systems. Using an established mouse model of rheumatoid arthritis, we show that chronic inflammatory arthritis results in rhythmic joint inflammation and drives major changes in muscle and liver energy metabolism and rhythmic gene expression. Transcriptional and phosphoproteomic analyses revealed alterations in lipid metabolism and mitochondrial function associated with increased EGFR-JAK-STAT3 signaling. Metabolomic analyses confirmed rhythmic metabolic rewiring with impaired β-oxidation and lipid handling and revealed a pronounced shunt toward sphingolipid and ceramide accumulation. The arthritis-related production of ceramides was most pronounced during the day, which is the time of peak inflammation and increased reliance on fatty acid oxidation. Thus, our data demonstrate that localized joint inflammation drives a time-of-day–dependent build-up of bioactive lipid species driven by rhythmic inflammation and altered EGFR-STAT signaling.

Identifiants

pubmed: 35482925
doi: 10.1073/pnas.2112781119
pmc: PMC9170023
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2112781119

Subventions

Organisme : Medical Research Council
ID : MR/W019000/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/S002715/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 107851/Z/15/2
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/P023576/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/P00279X/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/P023576/2
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 107849/Z/15/Z
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/V002651/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 107851/Z/15/Z
Pays : United Kingdom

Références

J Clin Invest. 2018 Jun 1;128(6):2281-2296
pubmed: 29533925
Front Endocrinol (Lausanne). 2019 Aug 21;10:577
pubmed: 31496996
Curr Opin Lipidol. 2012 Aug;23(4):321-6
pubmed: 22617755
Proc Natl Acad Sci U S A. 2020 Jan 21;117(3):1543-1551
pubmed: 31900362
FASEB J. 2016 Nov;30(11):3759-3770
pubmed: 27488122
FASEB J. 2017 Apr;31(4):1263-1272
pubmed: 28003342
Cell. 2016 May 5;165(4):896-909
pubmed: 27153497
Proc Natl Acad Sci U S A. 2012 Jan 10;109(2):582-7
pubmed: 22184247
Bioessays. 2015 Jul;37(7):777-88
pubmed: 26010005
PLoS Biol. 2019 Mar 1;17(3):e3000170
pubmed: 30822303
FEBS J. 2021 Jun 30;:
pubmed: 34189845
Sci Rep. 2016 Jul 21;6:29983
pubmed: 27439882
Nucleic Acids Res. 2016 Jul 8;44(W1):W90-7
pubmed: 27141961
Arthritis Res Ther. 2019 Feb 6;21(1):47
pubmed: 30728072
J Biol Chem. 1991 Aug 25;266(24):16092-7
pubmed: 1874747
Cell Metab. 2006 Aug;4(2):107-10
pubmed: 16890538
Nature. 2014 Jun 5;510(7503):58-67
pubmed: 24899305
Science. 2016 Nov 25;354(6315):994-999
pubmed: 27885004
BMC Bioinformatics. 2013 Apr 15;14:128
pubmed: 23586463
Mol Cell Biol. 2015 Aug;35(16):2752-60
pubmed: 26031333
EMBO Rep. 2016 Sep;17(9):1292-303
pubmed: 27418314
Arthritis Rheumatol. 2015 Mar;67(3):626-36
pubmed: 25504899
Sci Rep. 2019 Oct 25;9(1):15298
pubmed: 31653897
Nat Rev Dis Primers. 2018 Feb 08;4:18001
pubmed: 29417936
Cell. 2018 Sep 6;174(6):1571-1585.e11
pubmed: 30193114
Bioinformatics. 2016 Nov 1;32(21):3351-3353
pubmed: 27378304
Nat Rev Immunol. 2018 Jul;18(7):423-437
pubmed: 29662121
Nat Med. 2004 Feb;10(2):168-74
pubmed: 14716305
Cell. 2017 Aug 10;170(4):664-677.e11
pubmed: 28802039
Nat Commun. 2017 Nov 29;8(1):1849
pubmed: 29185442
Cell. 2019 May 30;177(6):1536-1552.e23
pubmed: 31150623
Cell. 2013 Dec 19;155(7):1464-78
pubmed: 24360271
N Engl J Med. 2021 Feb 11;384(6):550-561
pubmed: 33567194
Diabetes. 2013 Jun;62(6):1981-9
pubmed: 23382450
Nat Med. 2014 Aug;20(8):919-26
pubmed: 25064128
Cell Metab. 2007 Nov;6(5):414-21
pubmed: 17983587
Nat Rev Genet. 2017 Mar;18(3):164-179
pubmed: 27990019
Atherosclerosis. 2008 Feb;196(2):756-63
pubmed: 17266963
Genome Res. 2015 Dec;25(12):1848-59
pubmed: 26486724
Annu Rev Physiol. 2010;72:517-49
pubmed: 20148687
Bone Res. 2018 Apr 27;6:15
pubmed: 29736302
Ann Rheum Dis. 2009 Jan;68(1):63-8
pubmed: 18375536

Auteurs

Polly Downton (P)

Centre for Biological Timing, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, M13 9PT, United Kingdom.

Fabio Sanna (F)

National Institute for Health Research Oxford Biomedical Research Centre, John Radcliffe Hospital, Oxford, OX3 9DU, United Kingdom.
Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, OX3 9DU, United Kingdom.

Robert Maidstone (R)

Centre for Biological Timing, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, M13 9PT, United Kingdom.
National Institute for Health Research Oxford Biomedical Research Centre, John Radcliffe Hospital, Oxford, OX3 9DU, United Kingdom.
Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, OX3 9DU, United Kingdom.

Toryn M Poolman (TM)

National Institute for Health Research Oxford Biomedical Research Centre, John Radcliffe Hospital, Oxford, OX3 9DU, United Kingdom.
Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, OX3 9DU, United Kingdom.

Edward A Hayter (EA)

Centre for Biological Timing, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, M13 9PT, United Kingdom.

Suzanna H Dickson (SH)

Centre for Biological Timing, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, M13 9PT, United Kingdom.

Nick A Ciccone (NA)

National Institute for Health Research Oxford Biomedical Research Centre, John Radcliffe Hospital, Oxford, OX3 9DU, United Kingdom.
Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, OX3 9DU, United Kingdom.

James O Early (JO)

Centre for Biological Timing, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, M13 9PT, United Kingdom.

Antony Adamson (A)

Genome Editing Unit, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, M13 9PT, United Kingdom.

David G Spiller (DG)

Centre for Biological Timing, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, M13 9PT, United Kingdom.

Devin A Simpkins (DA)

Centre for Biological Timing, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, M13 9PT, United Kingdom.

Matthew Baxter (M)

National Institute for Health Research Oxford Biomedical Research Centre, John Radcliffe Hospital, Oxford, OX3 9DU, United Kingdom.
Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, OX3 9DU, United Kingdom.

Roman Fischer (R)

Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, OX3 7FZ, United Kingdom.

Magnus Rattray (M)

Centre for Biological Timing, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, M13 9PT, United Kingdom.

Andrew S I Loudon (ASI)

Centre for Biological Timing, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, M13 9PT, United Kingdom.

Julie E Gibbs (JE)

Centre for Biological Timing, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, M13 9PT, United Kingdom.

David A Bechtold (DA)

Centre for Biological Timing, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, M13 9PT, United Kingdom.

David W Ray (DW)

National Institute for Health Research Oxford Biomedical Research Centre, John Radcliffe Hospital, Oxford, OX3 9DU, United Kingdom.
Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, OX3 9DU, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH